121.00
-1.40 (-1.14%)
| 前收盘价格 | 122.40 |
| 收盘价格 | 128.00 |
| 成交量 | 359,925 |
| 平均成交量 (3个月) | 846,879 |
| 市值 | 292,437,696 |
| 市盈率 (P/E TTM) | 9.31 |
| 价格/销量 (P/S) | 65.25 |
| 股市价格/股市净资产 (P/B) | 1.07 |
| 52周波幅 | |
| 利润日期 | 28 Aug 2025 |
| 营业毛利率 | 1,108.33% |
| 营业利益率 (TTM) | -1,530.20% |
| 稀释每股收益 (EPS TTM) | 0.160 |
| 季度收入增长率 (YOY) | 2,422.20% |
| 总债务/股东权益 (D/E MRQ) | 40.59% |
| 流动比率 (MRQ) | 9.33 |
| 营业现金流 (OCF TTM) | -134.37 M |
| 杠杆自由现金流 (LFCF TTM) | -69.31 M |
| 资产报酬率 (ROA TTM) | -13.10% |
| 股东权益报酬率 (ROE TTM) | 6.41% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (GB) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | PURETECH HEALTH PLC ORD 1P | - | - |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | -2.5 |
| 平均 | -0.25 |
相关股票
| 股票 | 市值 | DY | P/E（TTM） | P/B |
|---|---|---|---|---|
| PURETECH HEALTH PLC ORD 1P | 292 M | - | 9.31 | 1.07 |
| RELIEF THERAPEUTICS HOLDING SA | 2 B | - | - | 1.08 |
| IDORSIA LTD IDORSIA N ORD SHS | 1 B | - | - | - |
| OXFORD NANOPORE TECHNOLOGIES PL | 1 B | - | - | 2.30 |
| IOVANCE BIOTHERAPEUTICS INC IOV | 304 M | - | - | - |
| FARON PHARMACEUTICALS OY ORD NP | 231 M | - | - | 165.73 |
|
PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 14.67% |
| 机构持股比例 | 66.90% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合